Odyssey Health, Inc. (ODYY) Stock Price & Analysis
Odyssey Health, Inc. (ODYY) rose 0.00% to USD 0.01 as of July 25, 2026 at 13:41 UTC, according to Nexqual real-time market data.
ODYY last closed at USD 0.01; the session ranged USD 0.01–0.01 on volume of 1,000 shares. Market capitalization is $706,780, with a 52-week range of USD 0.01–0.13 (OQB). Source: Nexqual, July 25, 2026 at 13:41 UTC.
Key Statistics (as of July 25, 2026 at 13:41 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0.01 – 0.13 |
| Volume | 1,000 shares |
| Market Cap | $706,780 |
| Exchange | OQB |
Technical Analysis (ODYY)
Nexqual's technical model rates ODYY "SELL" based on 2 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 13:41 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.11 (neutral) |
| vs SMA50 | Below (USD 0.01) |
| MACD | -0 (negative) |
Analyst Ratings (ODYY)
Wall Street analysts rate ODYY "None", per Nexqual as of July 25, 2026 at 13:41 UTC.
| Consensus Rating | None |
|---|
Earnings (ODYY)
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Financials & Fundamentals (ODYY)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.04 |
| Total Cash | $297,806 |
| Total Debt | $2.64M |
| Free Cash Flow | $2.04M |
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Financial Health Score (ODYY)
Nexqual rates Odyssey Health, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:41 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $298K cash vs $3M debt |
| Cash Flow | Weak — Operating cash flow -$935K |
| Efficiency | Mixed — No data |
Ownership (ODYY)
| Insider Ownership | +15.69% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 100.97M |
| Float | 85.13M |
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Leadership (ODYY)
Odyssey Health, Inc. is led by Joseph Michael Redmond (age 64), Chairman, President & CEO, per Nexqual as of July 25, 2026 at 13:41 UTC.
| Chairman, President & CEO | Joseph Michael Redmond (age 64) |
|---|---|
| CFO & Secretary | Christine M. Farrell (age 65) |
Major Backers & Investors (ODYY)
Notable institutional backers of Odyssey Health, Inc. include Orleans Capital Management Corp/LA, according to Nexqual as of July 25, 2026 at 13:41 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Orleans Capital Management Corp/LA | 1.03% |
Source: Nexqual, July 25, 2026 at 13:41 UTC.
From Odyssey Health, Inc.'s Latest SEC 10-K Filing (filed 2025-10-29)
Key Strengths & Strategy (as disclosed to the SEC)
- Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies.
- The company develops CardioMap, a heart monitoring and screening device; and Save A Life choking rescue devices.
- Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ADTI | Adapti, Inc. | USD 2.2 | ▼ 23.28% |
| EVAHF | EGF THERAMED HEALTH CORP. | USD 0.03 | ▲ 0% |
| PEMTF | THOUGHTFUL BRANDS INC | USD 0 | ▲ 0% |
| CPMD | Cannapharmarx Inc. | USD 0 | ▲ 0% |
| SPONF | SPONSORSONE INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:41 UTC. This page is informational and not investment advice.